Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MIMEDX GROUP, INC. Director's Dealing 2011

Jan 4, 2011

32206_dirs_2011-01-04_28665a03-40e0-44a6-aee9-5dfaba2c4321.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MIMEDX GROUP, INC. (MDXG)
CIK: 0001376339
Period of Report: 2010-12-31

Reporting Person: PETIT PARKER H (Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-11-15 Common Stock P 600000 $1.00 Acquired 3630258 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-10-20 5% Convertible Promissory Note $1.00 P 150000 Acquired 2010-12-31 Common Stock (150000) Direct
2010-10-20 Warrant $1.00 P 150000 Acquired 2013-10-20 Common Stock (150000) Direct
2010-11-04 5% Convertible Promissory Note $1.00 P 250000 Acquired 2010-12-31 Common Stock (250000) Direct
2010-11-04 Warrant $1.00 P 250000 Acquired 2013-11-04 Common Stock (250000) Direct
2010-12-31 Warrant $.60 G 280000 Disposed 2012-09-22 Common Stock (280000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrant $1.5 2015-11-15 Common Stock (300000) 4016666 Direct

Footnotes

F1: Number of shares held directly by Mr. Petit. Mr. Petit also beneficially owns 150,000 shares held by the Parker H. Petit Grantor Trust, of which he serves as the Trustee; 150,000 shares held by Petit Investments LP of which he serves as General Partner and Limited Partner and possesses shared voting and investment control; and 975,000 shares held by Cox Road Partners II LLP, 975,000 shares held by Cox Road Partners LLLP, and 975,000 shares held by Petit Investments LLLP II, limited liability limited partnerships over which Mr. Petit possesses sole voting and investment control.

F2: In conjunction with the 5% Convertible Promissory Note, the holder was issued warrants to purchase common stock.

F3: In conjunction with the purchase of common stock listed in table 1 above, the holder was issued warrants to purchase common stock.